Valuation: Masimo Corporation

Market Cap 9.42B 8.24B 7.6B 7.02B 13.32B 899B 13.55B 90.84B 35.67B 443B 35.38B 34.61B 1,522B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.6B 7.93B 7.33B 13.9B 938B 14.13B 94.76B 37.21B 462B 36.91B 36.11B 1,588B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
3 months+0.91%
6 months+29.53%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 51.1
Extreme 51.1
305.21
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Corporate Officer/Principal 62 01/07/2025
Director TitleAgeSince
Director/Board Member - 10/06/2026
Date Insider Type Main position Quantity % Market Cap.
10/06Issuer sale

Director

-4,134 0.0079%
10/06Issuer sale

Controller/Auditor

-24,592 0.0470%
10/06Issuer sale

Head of Human Resources

-14,097 0.0269%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+8.79%+13.45% 9.42B
-0.05%-0.15%+30.29%-2.90% 12.51B
-2.70%-5.50%+56.06%+31.24% 6B
+2.16%-0.14%+7.62%+14.59% 5.73B
-1.40%-2.68% - - 4.23B
+3.82%+5.08%-30.34%+15.21% 4.1B
+1.84%-0.61%-25.08%-26.66% 3.75B
-4.40%-4.94%-10.81%-60.73% 2B
+2.48%+3.12%+20.44%+266.67% 1.89B
-0.98%+1.78%+56.43%-5.02% 1.57B
Average +0.04%+0.25%+12.60%+27.32% 5.12B
Weighted average by Cap. +0.09%-0.14%+15.51%+14.86%

Financials

2024 2025
Net sales 2.09B 1.83B 1.69B 1.56B 2.96B 200B 3.01B 20.19B 7.93B 98.4B 7.86B 7.69B 338B 1.53B 1.34B 1.23B 1.14B 2.16B 146B 2.2B 14.72B 5.78B 71.74B 5.73B 5.61B 247B
Net income -305M -267M -246M -227M -431M -29.08B -438M -2.94B -1.15B -14.33B -1.14B -1.12B -49.25B -152M -133M -122M -113M -214M -14.45B -218M -1.46B -574M -7.12B -569M -556M -24.47B
Net Debt 668M 585M 539M 498M 945M 63.76B 961M 6.44B 2.53B 31.41B 2.51B 2.46B 108B 407M 356M 328M 303M 575M 38.82B 585M 3.92B 1.54B 19.12B 1.53B 1.49B 65.74B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock